Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neural cell adhesion molecule 1 (NCAM1), also known as CD56, is a multifunctional glycoprotein belonging to the immunoglobulin superfamily. It plays critical roles in cell adhesion, migration, signaling, and development across neural and immune systems. It exists as several isoforms (NCAM-180, NCAM-140, NCAM-120) and is widely expressed in neurons, glial cells, skeletal muscle, NK cells, T lymphocytes, B lymphocytes, and dendritic cells. Alterations in NCAM/CD56 expression or signaling have been linked to cognitive deficits such as schizophrenia or Alzheimer's disease, and hereditary motor sensory neuropathy (CMT).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neural cell adhesion molecule 1 (NCAM1).